Saba Capital discloses 9.16% stake in India fund
Rhea-AI Filing Summary
Saba Capital Management and affiliates have filed Amendment No. 6 to a Schedule 13D reporting a significant stake in Morgan Stanley India Investment Fund, Inc. The reporting group, including Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein, reports beneficial ownership of 873,236 common shares, equal to 9.16% of the fund’s outstanding common stock based on 9,534,799 shares outstanding as of 6/30/25.
The filing states that approximately $23,093,675 was paid to acquire these shares, using investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All recent trades within 60 days before 2/25/26 were executed in the open market and are detailed in Schedule A. The purpose of the transaction is described as not applicable, and the funds advised by Saba Capital are entitled to dividends and sale proceeds from the shares.
Positive
- None.
Negative
- None.
Insights
Saba Capital discloses a 9.16% position in Morgan Stanley India Investment Fund via Schedule 13D/A.
The filing shows Saba Capital, its general partner, and Boaz R. Weinstein jointly reporting 873,236 common shares of Morgan Stanley India Investment Fund, or 9.16% of shares outstanding as of 6/30/25. Total acquisition cost is about $23,093,675, funded by investor capital and ordinary-course margin borrowing.
A Schedule 13D typically signals an investor is taking an active interest, though the stated purpose here is “Not Applicable.” Actual impact depends on any future proposals or engagements that may be detailed in later disclosures, including how Saba exercises its shared voting and dispositive power over these shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Saba Capital report in Morgan Stanley India Investment Fund (IIF)?
How is the 9.16% ownership in IIF calculated for Saba Capital?
Who are the reporting persons on the IIF Schedule 13D/A filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.